GlassScriptPhysician profile
Muhammad Hassan
NPI 1609437839
$7,589.81
in general payments reported to CMS, 2019-2025
17 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $1,031 · 2023: $2,594 · 2024: $3,027 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,494 · Travel and Lodging: $1,104 · Consulting Fee: $1,100 · Honoraria: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,493.73 |
| Travel and Lodging | $1,103.86 |
| Consulting Fee | $1,100.00 |
| Honoraria | $460.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,927.86 | 2021-2024 | Clareon, Centurion, Argos |
| Eyepoint US, INC. | $1,267.13 | 2024 | |
| Alimera Sciences, INC. | $807.31 | 2023-2024 | Iluvien, Yutiq |
| Apellis Pharmaceuticals, INC. | $394.81 | 2023-2025 | Syfovre |
| Dutch Ophthalmic, USA | $340.93 | 2024-2025 | Tissueblue, Eva, Combined Machine |
| Regeneron Healthcare Solutions, INC. | $337.48 | 2023-2025 | Eylea Hd |
| Biogen, INC. | $219.16 | 2022-2024 | Byooviz |
| Genentech, INC. | $213.61 | 2022 | |
| Abbvie INC. | $189.12 | 2023-2025 | |
| Regeneron Pharmaceuticals, INC. | $168.48 | 2022-2023 | Eylea |
| Astellas Pharma US INC | $129.44 | 2023-2025 | Izervay |
| Spark Therapeutics, INC. | $125.00 | 2022 | |
| Stryker Corporation | $123.44 | 2023 | Na |
| Glaukos Corporation | $101.78 | 2022-2023 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $100.48 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Genentech USA, INC. | $43.79 | 2025 | Susvimo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.